A carregar...

Impact of Amyloid Imaging on Drug Development in Alzheimer’s Disease

Imaging agents capable of assessing amyloid-beta (Aβ) content in vivo in the brains of Alzheimer’s disease (AD) subjects likely will be important as diagnostic agents to detect Aβ plaques in the brain, to help test the amyloid cascade hypothesis of AD, and as an aid to assess the efficacy of anti-am...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Mathis, C.A., Lopresti, B.J., Klunk, W.E.
Formato: Artigo
Idioma:Inglês
Publicado em: 2007
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2078205/
https://ncbi.nlm.nih.gov/pubmed/17921032
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nucmedbio.2007.06.015
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!